InsidersTradesSigma
Track the 바이젠셀 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 바이젠셀 has published 2 public disclosures. Market capitalisation: €106.8bn. The latest transaction was disclosed on 31 March 2026 (Sale). Among the most active insiders: 가은글로벌. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
바이젠셀 es una empresa de salud y farmacéutica que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones innovadoras para el tratamiento de enfermedades.